Subscribe to RSS
DOI: 10.1055/s-0037-1608703
Metastatic Osseous Pain Control: Radiation Therapy
Publication History
Publication Date:
14 December 2017 (online)
![](https://www.thieme-connect.de/media/sir/201704/lookinside/thumbnails/10-1055-s-0037-1608703_001033-1.jpg)
Abstract
Metastatic disease to the bone is a common manifestation of advanced cancer, and can result in pain, pathologic fractures, hypercalcemia, and overall functional compromise. External beam radiation is a proven, highly efficacious, and noninvasive therapy that can provide symptomatic relief from painful osseous lesions. When deciding upon the best treatment regimen, it is important to consider patient factors such as overall life expectancy, performance status, disease burden, and site of osseous metastatic pain. Determination of best treatment ideally requires multidisciplinary input from radiologists, medical oncologists, surgeons, pain management, and palliative care specialists together with radiation oncologists.
-
References
- 1 Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007; 25 (11) 1423-1436
- 2 Gripp S, Mjartan S, Boelke E, Willers R. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth?. Cancer 2010; 116 (13) 3251-3256
- 3 Patel A, Dunmore-Griffith J, Lutz S, Johnstone PA. Radiation therapy in the last month of life. Rep Pract Oncol Radiother 2013; 19 (03) 191-194
- 4 Kapadia NS, Mamet R, Zornosa C, Niland JC, D'Amico TA, Hayman JA. Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer. Cancer 2012; 118 (17) 4339-4345
- 5 Huang J, Wai ES, Lau F, Blood PA. Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study. BMC Palliat Care 2014; 13 (01) 49
- 6 Tsao MN, Lloyd N, Wong RK. , et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 2012; 4 (04) CD003869
- 7 Fairchild A, Harris K, Barnes E. , et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 2008; 26 (24) 4001-4011
- 8 van der Linden YM, Lok JJ, Steenland E. , et al; Dutch Bone Metastasis Study Group. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 2004; 59 (02) 528-537
- 9 Steenland E, Leer JW, van Houwelingen H. , et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999; 52 (02) 101-109
- 10 Fairchild A, Barnes E, Ghosh S. , et al. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?. Int J Radiat Oncol Biol Phys 2009; 75 (05) 1501-1510
- 11 Lutz S, Berk L, Chang E. , et al; American Society for Radiation Oncology (ASTRO). Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 79 (04) 965-976
- 12 Lutz S, Balboni T, Jones J. , et al. Palliative radiation therapy for bone metastases: update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 2017; 7 (01) 4-12
- 13 Hahn C, Kavanagh B, Bhatnagar A. , et al. Choosing wisely: the American Society for Radiation Oncology's top 5 list. Pract Radiat Oncol 2014; 4 (06) 349-355
- 14 Fischberg D, Bull J, Casarett D. , et al; HPM Choosing Wisely Task Force. Five things physicians and patients should question in hospice and palliative medicine. J Pain Symptom Manage 2013; 45 (03) 595-605
- 15 Raman S, Chow R, Hoskin P, Chow E. How should radiation oncologists interpret the ASTRO evidence-based guideline and ASTRO Choosing Wisely campaign for the treatment of uncomplicated bone metastases?. Pract Radiat Oncol 2017; 7 (01) 13-15
- 16 Sze WM, Shelley M, Held I, Mason M. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. Cochrane Database Syst Rev 2004; (02) CD004721
- 17 Hartsell WF, Scott CB, Bruner DW. , et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005; 97 (11) 798-804
- 18 Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials. Clin Oncol (R Coll Radiol) 2003; 15 (06) 345-352
- 19 Foro Arnalot P, Fontanals AV, Galcerán JC. , et al. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol 2008; 89 (02) 150-155
- 20 Lutz S, Spence C, Chow E, Janjan N, Connor S. Survey on use of palliative radiotherapy in hospice care. J Clin Oncol 2004; 22 (17) 3581-3586
- 21 Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 1999; 52 (02) 111-121
- 22 Chang S, Cardinale BS, Morrison RS, Rosenzweig K, Dharmarajan KV. A palliative radiation oncology consult service's impact on care of advanced cancer patients with symptomatic bone metastases. J Clin Oncol 2015; 33 (29) 110
- 23 Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine 2007; 32 (02) 193-199
- 24 Sahgal A, Larson DA, Chang EL. Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys 2008; 71 (03) 652-665
- 25 Group RS. . Available at: https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0631
- 26 Westhoff PG, de Graeff A, Monninkhof EM. , et al; Dutch Bone Metastasis Study Group. An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases. Int J Radiat Oncol Biol Phys 2014; 90 (04) 739-747
- 27 Bickel KE, McNiff KK, Buss MK. , et al. Defining high-quality palliative care in oncology practice: an ASCO/AAHPM Guidance Statement. J Clin Oncol 2015; 33 (29) 108
- 28 McCloskey SA, Tao ML, Rose CM, Fink A, Amadeo AM. National survey of perspectives of palliative radiation therapy: role, barriers, and needs. Cancer J 2007; 13 (02) 130-137
- 29 Westhoff PG, Verdam MGE, Oort FJ. , et al; Dutch Bone Metastasis Study Group. Course of quality of life after radiation therapy for painful bone metastases: a detailed analysis from the Dutch Bone Metastasis Study. Int J Radiat Oncol Biol Phys 2016; 95 (05) 1391-1398
- 30 Li D, Prigerson HG, Kang J, Maciejewski PK. Impact of radiation therapy on aggressive care and quality of life near death. J Pain Symptom Manage 2017; 53 (01) 25-32
- 31 Chow E, Loblaw A, Harris K. , et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a pilot study. Support Care Cancer 2007; 15 (06) 643-647
- 32 Lam TC, Uno H, Krishnan M. , et al. Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: role of spinal instability and single-fraction radiation therapy. Int J Radiat Oncol Biol Phys 2015; 93 (02) 373-381
- 33 Huisman M, van den Bosch MA, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM. Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 2012; 84 (01) 8-14
- 34 Chow E, van der Linden YM, Roos D. , et al. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol 2014; 15 (02) 164-171
- 35 Chow E, Meyer RM, Chen BE. , et al. Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial. J Clin Oncol 2014; 32 (34) 3867-3873
- 36 Roos DE, Turner SL, O'Brien PC. , et al; Trans-Tasman Radiation Oncology Group, TROG 96.05. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005; 75 (01) 54-63